Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitus.

Trial Profile

Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitus.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Ramipril (Primary) ; Hydrochlorothiazide
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2014 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 27 May 2014 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 03 May 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top